What is icadmed.com?
ProFound AI is an AI‑powered platform that delivers breast cancer detection, density assessment, and risk evaluation for 2D and 3D mammography. The detection module provides computer‑aided findings that help radiologists identify invasive cancers and interval cancers with higher sensitivity and reduced recall rates.
The density assessment module generates objective, consistent breast‑density scores that inform risk stratification and treatment planning. The risk evaluation module uses an image‑based model that is up to 2.4 × more accurate than traditional risk calculators, enabling clinicians to identify high‑risk women before or at their next screening.
ProFound AI is FDA‑Cleared (Detection and Density modules) and CE‑Marked, with flexible deployment options that integrate into existing PACS and reading workstations, streamlining workflow and reducing reading time for providers while providing patients with earlier, more accurate breast cancer screening.
icadmed.com user reviews
Would you recommend icadmed.com?
icadmed.com's key features
-
AI-powered breast cancer detection
-
Density assessment for breast tissue
-
Image-based risk evaluation
-
Supports 2D and 3D mammography
-
FDA cleared and CE marked
-
Flexible deployment options
-
Seamless workflow integration
icadmed.com use cases
-
Use ProFound AI to automatically flag potential malignancies in mammograms, cutting recall rates and accelerating radiologist workflow
-
Employ ProFound AI’s density scoring to stratify patients into risk categories, enabling personalized screening intervals and treatment planning
-
Integrate ProFound AI with PACS and EMR to generate seamless risk assessment reports, streamlining clinical decision support and reducing manual data entry
Who is it for?
-
Medical imaging technicians
-
Cancer survivors
-
Diagnostic physicians
-
Clinical researchers
-
Healthcare administrators
